Scientific article
OA Policy
English

Recent advances in intra-articular drug delivery systems for osteoarthritis therapy

Published inDrug Discovery Today, vol. 23, no. 10, p. 1761-1775
Publication date2018
Abstract

Osteoarthritis (OA) is the most common degenerative disease of the joint. Despite many reports and numerous clinical trials, OA is not entirely understood, and there is no effective treatment available for this disease. To satisfy this unmet medical need, drug delivery systems (DDSs) containing disease-modifying OA drugs (DMOADs) for intra-articular (IA) administration are required to improve the health of OA patients. DDSs should provide controlled and/or sustained drug release, enabling long-term treatment with a reduced number of injections. This paper reviews the role and interaction among different tissues involved in OA and summarizes recent clinical trials and research on DDSs, focusing on small-molecule delivery. To achieve an ideal treatment, various key criteria have been identified to design and develop an IA DDS matching the clinical needs.

Keywords
  • Animals
  • Antirheumatic Agents/administration & dosage
  • Delayed-Action Preparations
  • Drug Delivery Systems
  • Drug Design
  • Drug Development/methods
  • Humans
  • Injections, Intra-Articular
  • Osteoarthritis/drug therapy/physiopathology
Citation (ISO format)
MAUDENS, Pierre Marc Xavier, JORDAN, Olivier, ALLÉMANN, Eric. Recent advances in intra-articular drug delivery systems for osteoarthritis therapy. In: Drug Discovery Today, 2018, vol. 23, n° 10, p. 1761–1775. doi: 10.1016/j.drudis.2018.05.023
Main files (1)
Article (Accepted version)
Identifiers
Journal ISSN1359-6446
292views
941downloads

Technical informations

Creation25/08/2020 11:01:00
First validation25/08/2020 11:01:00
Update time15/03/2023 22:34:58
Status update15/03/2023 22:34:57
Last indexation31/10/2024 19:40:32
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack